This video is about the CRO (Contract Research Organization) being sold to Pamplona Capital Management at the end of 2017. Parexel is one of my colleagues favorite CRO's because of their management style, but we knew something was up when they started laying off a bunch of CMA's (clinical monitoring associate's) and effectively deleting the position from their repertoire.
Don't forget to Subscribe for new content! Hear my take on the CRO giant Parexel getting bought by Pamplona Capital and what it will/ has done to the clinical research space.
Become a supporter of this podcast:
https://anchor.fm/clinical-research-podcast/support
view more